White Papers
Our white papers are written by technical experts from many different fields, exploring and commentating on a range of complex subjects.
|
A Consideration of H1N1/09pdm and New Variant H3N2/13 as Agents for Human Challenge Trials
Within the field of influenza research, there is becoming an increasingly large place for Human or Viral Challenge Trials (HCT). |
|---|---|
|
Sputum Induction Method to Optimize Respiratory Patient Clinical Trials
This white paper will examine the use of sputum induction as a pharmacodynamic method to optimize respiratory patient clinical trials, including comparison to other methods, and a case study looking at asthma patients and healthy volunteers. |
|
Early Phase Clinical Trials in Patients with Hepatic or Renal Impairment
FDA and EMA guidances are intended to help companies evaluate the need for conducting PK studies in renal and hepatic impaired patients. Although many procedural recommendations exist, some key questions still need to be investigated case-by-case at the early stage of the project development. |
|
Keeping Metallic and Non Metallic Surfaces Free of Oil and Grease
Various branches of industry are placing increasing value on the cleanliness of manufacturing components. Learn more about how SGS developed an appropriate preparation processes for investigations to determine the amount of oil and grease present on metallic and non-metallic surfaces. |
|
Öl- und Fettfreiheit auf metallischen und nichtmetallischen Oberflächen
Verschiedene Industriezweige legen immer größeren Wert auf die Sauberkeit von Bauteilen. Lesen Sie wie die SGS Präparationsverfahren für die Untersuchungen zum Öl- und Fettgehalt auf metallischen und nichtmetallischen Oberflächen weiterentwickelt. |
|
Primary and Higher-Order Structural Characterization Strategy for Biosimilarity Assessment
This article addresses some issues involved in meeting regulatory characterization expectations for biosimilars. |
|
RoHS II: Meet the Compliance Challenge
Why complying with the European Union's new Directive on restricted substances may be more challenging than it appears. |
|
Understanding Safety, Quality and Supply Chain Best Practice in the Dairy Industry
We discuss the current state of the global dairy industry and considerations for safety, quality and supply chain management. |
|
A Guide to Biologic Stability Testing
This article provides a complete view of stability studies on biologics. The end goal is to help drug developers save unnecessary costs and delays in their timelines, and facilitate getting safer medicines to patients. |
|
End Customers' Perspectives on Policies and Extended Warranties: SGS German Policy Survey
The SGS 2015 Policy Survey is the sequel to a previous survey reflecting customer and dealer satisfaction with Original Equipment Manufacturer (OEM) warranty processes. |